Cargando…
Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma
Endometrial carcinoma is the most common malignancy of the female genital tract and is the fourth most common malignancy among women worldwide. Endometrial adenocarcinoma (EAC) accounts for ~80% of endometrial carcinoma cases. Numerous critical genetic events have been determined to serve an essenti...
Autores principales: | Deng, Xinchao, Hou, Congzhe, Wang, Huali, Liang, Tingting, Zhu, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865881/ https://www.ncbi.nlm.nih.gov/pubmed/28944908 http://dx.doi.org/10.3892/mmr.2017.7564 |
Ejemplares similares
-
miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma
por: Deng, Xinchao, et al.
Publicado: (2017) -
An Eye on the Wnt Inhibitory Factor Wif1
por: Poggi, Lucia, et al.
Publicado: (2018) -
Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review
por: Guo, Hao, et al.
Publicado: (2016) -
MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1
por: Zhang, Ping, et al.
Publicado: (2017) -
Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma
por: Liu, Pei, et al.
Publicado: (2017)